CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...